Target intelligence / Profile preview

Systemic iron-binding and storage proteins

Molecular classification
Iron-binding protein, Iron storage protein, Iron transport protein, Acute phase reactant
01

Overview

Systemic iron-binding and storage proteins are a group of specialized molecules, including transferrin, ferritin, lactoferrin, haptoglobin, and hemopexin, that regulate iron distribution and prevent its toxicity. Transferrin is the primary transport protein that delivers iron to tissues via receptor-mediated endocytosis, while ferritin serves as the major storage protein, sequestering iron in a non-reactive mineral core. These proteins are essential for preventing the Fenton reaction, which produces damaging free radicals, and for nutritional immunity, which restricts iron access for pathogens. In clinical practice, these proteins are targeted by iron chelators (e.g., deferoxamine) to treat iron overload and by iron supplements (e.g., ferrous sulfate) to treat iron deficiency. They also serve as critical diagnostic biomarkers, with serum ferritin and transferrin saturation being the gold standards for assessing a patient's iron status. Dysregulation of these proteins is implicated in various diseases, including hereditary hemochromatosis, anemia of chronic disease, and neurodegenerative disorders.

Other names
Iron-binding proteinsIron storage proteinsIron transport and storage systemSiderophilins
02

Mechanism of action

Iron chelation (binding and removal of iron from protein stores), Iron supplementation (replenishing iron to saturate transport and storage proteins), and Heme/Hemoglobin sequestration (binding free heme/hemoglobin to prevent toxicity).

03

Biological functions

Iron homeostasisNutritional immunityAntioxidant activityOxygen transportImmune response
04

Disease associations

Iron deficiency anemiaHemochromatosisThalassemiaAnemia of chronic diseaseNeurodegenerative diseaseInfection
05

Safety considerations

Iron toxicityOxidative stressHypersensitivity reactionsGastrointestinal irritationRisk of infection by siderophilic bacteria
06

Interacting drugs

Deferoxamine

8 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturation (TSAT)Total iron-binding capacity (TIBC)Soluble transferrin receptor (sTfR)Serum iron

Beyond the preview

Go deeper on Systemic iron-binding and storage proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic iron-binding and storage proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call